ArticleJournal of computer-aided molecular design2026
A Multimodal deep learning method for predicting drug-induced liver injury using structural and sequential molecular representations.
Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- TechBio 3.0 closes the drug discovery loop with multimodal AI and generative chemistry.npj drug discovery · 2026Review
- Chemical language models for early-stage drug discovery: applications, pitfalls, and future directions.Journal of computer-aided molecular design · 2026Review
- Multimodal machine learning and deep graph neural networks for the prediction of molecular inhibitory activity and disease associations.Journal of computer-aided molecular design · 2026Article
- Interpreting the Black Box: Interpretable Machine Learning and Systems Pharmacology in Small-Molecule Therapeutics.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced liver injury (DILI) remains one of the leading causes of drug development failure and post-marketing withdrawal. Despite recent advances in computational modeling, many existing approaches rely heavily on structural features such as molecular fingerprints, often neglecting the rich sequential information encoded in SMILES representations. In this study, we propose a multimodal deep learning framework that integrates both substructural features and sequential information to improve the prediction of DILI. Specifically, we utilize a diverse array of molecular fingerprints-KlekotaRoth, CDKExtended, MACCS, PubChem, Estate, Avalon, ECFP2, Morgan, and RDKit-to capture the structural aspects of molecules. In parallel, we use ChemBERTa, RoBERTa, ChemBERTaV2, and SMILES2Vec to extract high-level sequential information from SMILES strings. By fusing complementary modalities, our approach achieves superior performance compared to single modality methods. Furthermore, an ablation study reveals the synergistic contribution of both modalities in capturing the complex biological mechanisms underlying liver toxicity. Our findings underscore the importance of multimodal integration in developing more accurate and generalizable predictive models for DILI.
Indexed as
Identifiers
41882435What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.